Pfizer, Inc. vs Stryker Corporation — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
SYK
Consensus analyst target of $394.12 is 34% above current price.
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $394.12 (+33.7%)
26 analysts
Fundamentals
PFE
SYK
19.4×
Trailing P/E
35.1×
9.4×
Forward P/E
17.6×
12.4%
Profit Margin
13.2%
75.8%
Gross Margin
64.7%
8.9%
ROE
15.2%
-1.2%
Revenue Growth
2.6%
—
Earnings Growth
14.2%
0.39
Beta
0.93
—
Price / Book
—
$149.8B
Market Cap
$112.9B
$22 – $29
52-Week Range
$295 – $405
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →